Convatec Group (CTEC)

Sector:

Health Care

Index:

FTSE 100

243.60p
   
  • Change Today:
    -1.40p
  • 52 Week High: 256.40p
  • 52 Week Low: 194.00p
  • Currency: UK Pounds
  • Shares Issued: 1,912.23m
  • Volume: 673,101
  • Market Cap: £4,658.19m
  • RiskGrade: 96
  • Beta: 0.00

CTEC Overview

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. Its products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. Based in Reading, it employs over 9,000 people in more than 100 countries.
Competitors: Consort Medical

Key Personnel

Chairman: John McAdam
CEO: Jonny Mason
CFO: Fiona Ryder
Independent Non-Executive Director: Brian May
Independent Non-Executive Director: Heather Mason
Independent Non-Executive Director: Kimberly Lody
Independent Non-Executive Director: Sharon O'Keefe
Senior Independent Non-Executive Director: Margaret Ewing
Non-Executive Dir: Tobias Hestler, Jens Viebke

Contact Details

Address: 7th Floor, 20 Eastbourne Terrace, London, United Kingdom, W2 6LG
Phone: +44 (0) 118 952 8100
Website: http://www.convatecgroup.com

Listings

Sector: Health Care(LSE)
Index: FTSE 100, FTSE 350, FTSE All-Share
ISIN: GB00BD3VFW73

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

CTEC Market Data

Currency UK Pounds
Share Price 243.60p
Change Today -1.40p
% Change -0.57 %
52 Week High 256.40p
52 Week Low 194.00p
Volume 673,101
Shares Issued 1,912.23m
Market Cap £4,658.19m
Beta 0.00
RiskGrade 96

CTEC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.56% below the market average92.56% below the market average92.56% below the market average92.56% below the market average92.56% below the market average
61.54% below the sector average61.54% below the sector average61.54% below the sector average61.54% below the sector average61.54% below the sector average
Price Trend
8.45% above the market average8.45% above the market average8.45% above the market average8.45% above the market average8.45% above the market average
37.93% above the sector average37.93% above the sector average37.93% above the sector average37.93% above the sector average37.93% above the sector average
Income
68.47% below the market average68.47% below the market average68.47% below the market average68.47% below the market average68.47% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
41.97% above the market average41.97% above the market average41.97% above the market average41.97% above the market average41.97% above the market average
21.43% below the sector average21.43% below the sector average21.43% below the sector average21.43% below the sector average21.43% below the sector average

What The Brokers Say

Strong Buy 8
Buy 7
Neutral 2
Sell 0
Strong Sell 0
Total 17
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CTEC Dividends

  Latest Previous
  Interim Final
Ex-Div 20-Aug-26 16-Apr-26
Paid 30-Sep-26 28-May-26
Amount 2.17¢ 5.37¢

Trades for 27-Oct-2026

Time Volume / Share Price
12:13 1,251 @ 243.60p
12:09 22 @ 243.60p
12:06 13,796 @ 243.60p
12:06 13,796 @ 243.60p
12:05 1,050 @ 243.60p

CTEC Key Personnel

Chair John McAdam
CEO Jonny Mason
CFO Fiona Ryder

Top of Page